SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001193125-08-117056
Filing Date
2008-05-16
Accepted
2008-05-16 10:13:40
Documents
3

Document Format Files

Seq Description Document Type Size
1 424 d424b3.htm 424B3 1056856
2 GRAPHIC g42631img01.jpg GRAPHIC 7030
3 GRAPHIC g42631img02a.jpg GRAPHIC 4276
  Complete submission text file 0001193125-08-117056.txt   1074077
Mailing Address 324 SOUTH HYDE PARK AVE SUITE 350 TAMPA FL 33606
Business Address 324 SOUTH HYDE PARK AVE SUITE 350 TAMPA FL 33606 8138642562
ACCENTIA BIOPHARMACEUTICALS INC (Filer) CIK: 0001310094 (see all company filings)

IRS No.: 000000000
Type: 424B3 | Act: 33 | File No.: 333-132237 | Film No.: 08840559
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1